SCHEMBL690825

SCHEMBL690825

CCCCCCCCCCCCCCC(O)C(O)(O)C(O)(O)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 8/20 0.50
FFAR1 O14842 2/20 0.50
HSPD1 P10809 1/20 0.46
BLM P54132 1/20 0.46
HSPE1 P61604 1/20 0.46
FFAR4 Q5NUL3 1/20 0.46
MAPT P10636 1/20 0.44
LCK P06239 1/20 0.44
PPARD Q03181 1/20 0.44
ZDHHC20 Q5W0Z9 1/20 0.44
ZDHHC2 Q9UIJ5 1/20 0.44
MEN1 O00255 1/20 0.42
HPGD P15428 1/20 0.42
RECQL P46063 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42
ACE2 Q9BYF1 1/20 0.42
FDPS P14324 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1326141 1.00 GPR84 (0.50) GPR84FFAR1HSPD1BLMHSPE1
Glycerin SCHEMBL760417 0.93 GPR84 (0.46) GPR84FFAR1HSPD1BLMHSPE1
SCHEMBL30693672 0.92 CA2 (0.41) GPR84FFAR1HSPD1BLMHSPE1
SCHEMBL28496979 0.89 GPR84 (0.47) GPR84FFAR1HSPD1BLMHSPE1
SCHEMBL29034305 0.87 GPR84 (0.39) GPR84FFAR1HSPD1BLMHSPE1
Oleic Acid SCHEMBL28633048 0.84 FFAR1 (0.61) FFAR1BLMFFAR4MAPTPPARD
SCHEMBL10619537 0.84 CHRM1 (0.39) GPR84FFAR1HSPD1BLMHSPE1
SCHEMBL3960483 0.82 GPR84 (0.45) GPR84FFAR1HSPD1BLMHSPE1
SCHEMBL11705185 0.82 GPR84 (0.45) GPR84FFAR1HSPD1BLMHSPE1
SCHEMBL15367407 0.82 GPR84 (0.45) GPR84FFAR1HSPD1BLMHSPE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024237269-A1 HAIR TREATMENT AGENT 日光ケミカルズ株式会社 2024-11-21 WO claimed
US-20240247157-A1 TRIAZINE BASED ULTRAVOLET ABSORPTION POLYMER BASF SE (DE) 2024-07-25 US claimed
WO-2024071406-A1 WATER-IN-OIL EMULSION COMPOSITION 持田製薬株式会社 2024-04-04 WO claimed
CN-115475110-B Composition with after-sun repair effect and coated with composite peptide and preparation method thereof 陕西慧康生物科技有限责任公司 2024-03-26 CN claimed
EP-4334373-A1 TRIAZINE BASED ULTRAVOLET ABSORPTION POLYMER BASF SE (DE) 2024-03-13 EP claimed
US-20240049760-A1 SAFE-TO-INGEST MICROEMULSIONS AND NANOEMULSIONS CONTAINING LIPOPHILIC COMPONENTS CZUPIEL PETRO PAWLO (CA) 2024-02-15 US claimed
CN-117242116-A Triazinyl ultraviolet absorbing polymers 巴斯夫欧洲公司 2023-12-15 CN claimed
WO-2023028708-A1 WATER-SOLUBLE CANNABINOID COMPOSITIONS, METHODS OF MAKING AND USE CANOPY GROWTH CORPORATION (CA) 2023-03-09 WO claimed
CN-115475110-A Composition with after-sun repair effect and coated with composite peptide and preparation method thereof 陕西慧康生物科技有限责任公司 2022-12-16 CN claimed
WO-2022233760-A1 TRIAZINE BASED ULTRAVOLET ABSORPTION POLYMER BASF SE (DE) 2022-11-10 WO claimed
WO-2022137215-A1 SAFE-TO-INGEST CATIONIC MICROEMULSIONS AND NANOEMULSIONS CONTAINING LIPOPHILIC COMPONENTS CZUPIEL PETRO PAWLO (CA) 2022-06-30 WO claimed
WO-2022021769-A1 AMBROXOL HYDROCHLORIDE ORAL SPRAY SOLUTION AND PREPARATION METHOD THEREFOR 德国吉麦医疗技术有限公司 2022-02-03 WO claimed
EP-3823585-A1 NANOEMULSION HYDROPHOBIC SUBSTANCES Vertosa Inc. (US) 2021-05-26 EP claimed
CN-112057406-A Bicontinuous clear and thorough cleansing oil and preparation method thereof 上海典雅生物科技有限公司 2020-12-11 CN claimed
WO-2020018512-A1 NANOEMULSION HYDROPHOBIC SUBSTANCES NANOGEN LAB, INC. (US) 2020-01-23 WO claimed
EP-2288416-B2 HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS GOJO IND INC (US) 2014-12-24 EP claimed
EP-2288416-B1 HYDROALCOHOLIC GEL COMPOSITIONS FOR USE WITH DISPENSERS GOJO IND INC (US) 2012-02-29 EP claimed
US-20260137611-A1 NOVEL COMPOSITIONS DSM IP ASSETS B V (NL) 2026-05-21 US disclosed
EP-1857099-A1 Cosmetic or dermatological composition based on Kalanchoe linearifolia plant extracts Laboratoires Dermatologiques d'Uriage (FR) 2007-11-21 EP disclosed
EP-1854452-A1 Cosmetic or dermatological composition based on Vernonia sublutea plant extracts Laboratoires Dermatologiques d'Uriage (FR) 2007-11-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260137611-A1 NOVEL COMPOSITIONS SSB, BRCA1, TYR GPR84 4567/4885FFAR1 4121/4885HSPD1 2917/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.